Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial.

No differences were observed in overall circulating T helper (p=0.76), T-regs (p=0.12) and T suppressor (p=0.10) absolute counts, although a small and marginally significant reduction in T-regs/T-eff count and % were observed (p=0.05 and p=0.04, respectively) ( Figure 4 and Supplementary Table 6 ).

also in 26,082 other papers